Lentivirus-mediated knockdown of NOB1 suppresses the proliferation of colon cancer cells

Zeitschrift fur Gastroenterologie

Volumn 52, Issue 5, 2014, Pages 429-435

  Liu, Y ^a   Huang, H ^a   Yuan, B ^a   Zhuang, L Y ^a   Luo, T P ^a   Zhang, Q ^a  

^a Changzhou Hospital of Traditional Chinese Medicine   (China)

Author keywords

colon cancer; gastroenteropancreatic tumors; gastrointestinal bleeding; gastrointestinal stroma tumor (GIST); lentivirus; NOB1; shRNA

Indexed keywords

ARTICLE; CANCER CELL; CANCER CELL LINE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE SILENCING; HCT116 CELL LINE; HUMAN; HUMAN CELL; LENTIVIRINAE; MTT ASSAY; NOB1 GENE; SUPPRESSOR CELL; CELL CYCLE; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LENTIVIRUS;

EID: 84901064754     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0033-1356338     Document Type: Article

References (24)

1. Su S. Y., Huang J. Y., Jian Z. H. et al. Mortality of colorectal cancer in Taiwan, 1971-2010: temporal changes and age-period-cohort analysis. Int J Colorectal Dis: 2012; 27 1665 1672
2. Montanaro L., Trere D., Derenzini M. Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim Biophys Acta: 2012; 1825 101 110
3. Ge N. L., Rudikoff S. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo. Oncogene: 2000; 19 4091 4095
4. Ciechanover A., DiGiuseppe J. A., Bercovich B. et al. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci U S A: 1991; 88 139 143 (Pubitemid 21914443)
5. Mani A., Gelmann E. P. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol: 2005; 23 4776 4789 (Pubitemid 46224082)
6. Ciechanover A., Finley D., Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell: 1984; 37 57 66 (Pubitemid 14079836)
7. Voorhees P. M., Dees E. C., O'Neil B. et al. The proteasome as a target for cancer therapy. Clin Cancer Res: 2003; 9 6316 6325 (Pubitemid 38031815)
8. Gillessen S., Groettup M., Cerny T. The proteasome, a new target for cancer therapy. Onkologie: 2002; 25 534 539 (Pubitemid 36173392)
9. Hallahan D. E., Teng M. The proteasome: a molecular target for cancer therapy. Int J Radiat Oncol Biol Phys: 2000; 47 859 860 (Pubitemid 30345580)
10. Almond J. B., Cohen G. M. The proteasome: a novel target for cancer chemotherapy. Leukemia: 2002; 16 433 443 (Pubitemid 34449723)
11. Ludwig H., Viterbo L., Greil R. et al. Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma. J Clin Oncol: 2012; 31 247 255
12. Zemp I., Kutay U. Nuclear export and cytoplasmic maturation of ribosomal subunits. FEBS Lett: 2007; 581 2783 2793 (Pubitemid 46881154)
13. Fatica A., Oeffinger M., Dlakic M. et al. Nob1p is required for cleavage of the 3' end of 18S rRNA. Mol Cell Biol: 2003; 23 1798 1807 (Pubitemid 36246059)
14. Pertschy B., Schneider C.,Gnadig M. et al. RNA helicase Prp43 and its co-factor Pfa1 promote 20 to 18 S rRNA processing catalyzed by the endonuclease Nob1. J Biol Chem: 2009; 284 35079 35091
15. Wild T., Horvath P., Wyler E. et al. A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. PLoS Biol: 2010; 8 e1000522
16. Wyler E., Zimmermann M., Widmann B. et al. Tandem affinity purification combined with inducible shRNA expression as a tool to study the maturation of macromolecular assemblies. RNA: 2011; 17 189 200
17. Tone Y., Tanahashi N., Tanaka K. et al. Nob1p, a new essential protein, associates with the 26S proteasome of growing saccharomyces cerevisiae cells. Gene: 2000; 243 37 45 (Pubitemid 30079703)
18. Tone Y., Toh E. A. Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae. Genes Dev: 2002; 16 3142 3157 (Pubitemid 36025969)
19. Huang W. Y., Chen D. H., Ning L. et al. siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells. Asian Pac J Cancer Prev: 2012; 13 1823 1827
20. Oehler V. G., Yeung K. Y., Choi Y. E. et al. The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data. Blood: 2009; 114 3292 3298
21. Veith T., Martin R., Wurm J. P. et al. Structural and functional analysis of the archaeal endonuclease Nob1. Nucleic Acids Res: 2012; 40 3259 3274
22. Lu Z., Guo Q., Shi A. et al. Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells. Mol Biol Rep: 2012; 39 501 507
23. Lin Y., Peng S., Yu H. et al. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol: 2012; 29 311 317
24. Burger K., Muhl B., Harasim T. et al. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J Biol Chem: 2010; 285 12416 12425